Dysfunctional inflammasome in Schnitzler's syndrome
Authors:
- Marcello GovoniMGMarcello Govoni
- R. L. CorteRCR. L. Corte
- F. D. VirgilioF. D. Virgilio
- Andrea Lo MonacoAMAndrea Lo Monaco
Open Access
- 20 August 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 48 (10) , 1304-1308
Abstract
Objective. IL-1β plays a key role in the pathogenesis of Schnitzler's syndrome (SS). We have investigated inflammasome activity in peripheral blood mononuclear cells (PBMCs) from a patient affected by a variant type of SS. Methods. PBMCs were purified by Ficoll and examined for ability to secrete IL-1β and -18, expression and function of the P2X7 receptor and expression of apoptosis-associated speck-like protein containing a caspase recruitment domaine (ASC) and NOD-like receptor protein 3 (NLRP3) before and after the therapy with steroid. Furthermore, extracellular adenosine 5′-triphosphate (ATP) blood levels were determined by luciferase assay. Expression of inflammasome components was measured by real time PCR and western blotting. Results. PBMCs of patient with SS showed a high, spontaneous and lipopolysaccharide-stimulated, IL-1β release but low response to stimulation with the P2X7 agonist benzoyl ATP. P2X7 expression was several fold increased, whereas ASC expression was dramatically decreased compared with PBMCs from healthy controls. NLRP3 expression was unchanged. Prednisone treatment induced remission of clinical symptoms and normalized IL-1β secretion and P2X7 and ASC expression. Conclusion. These findings reveal the presence of an overall derangement of the inflammasome and IL-1β processing and release in SS.Keywords
This publication has 15 references indexed in Scilit:
- ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine wayProceedings of the National Academy of Sciences, 2008
- Primer: inflammasomes and interleukin 1β in inflammatory disordersNature Clinical Practice Rheumatology, 2008
- Pattern of interleukin‐1β secretion in response to lipopolysaccharide and ATP before and after interleukin‐1 blockade in patients with CIAS1 mutationsArthritis & Rheumatism, 2007
- Beneficial response to anakinra and thalidomide in Schnitzler's syndromeAnnals of the Rheumatic Diseases, 2006
- Cryopyrin activates the inflammasome in response to toxins and ATPNature, 2006
- Blocking IL-1 in systemic inflammationJournal of Experimental Medicine, 2005
- The InflammasomeMolecular Cell, 2002
- The Schnitzler SyndromeMedicine, 2001
- Purinergic Modulation of Interleukin-1β Release from Microglial Cells Stimulated with Bacterial EndotoxinJournal of Experimental Medicine, 1997
- The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role.Journal of Clinical Investigation, 1995